828 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
REGN Regeneron Pharmaceuticals, Inc. $386.665 $41.78B Buy
Article Searches
The Week That Was In San Francisco: 2019 Should Be A Great Year For Healthcare Stocks https://seekingalpha.com/article/4234239-week-san-francisco-2019-great-year-healthcare-stocks?source=feed_all_articles Jan 18, 2019 -
Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies http://www.zacks.com/stock/news/348354/aeries-aeri-eye-care-candidate-to-enter-clinical-studies?cid=CS-ZC-FT-348354 Jan 18, 2019 - Aerie's (AERI) Investigational New Drug Application for AR-1105 for the treatment of macular edema due to retinal vein occlusion is accepted by the FDA. The candidate will now enter clinical studies.
Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus http://www.zacks.com/stock/news/346497/biotech-stock-roundup-loxo-celg-gain-jp-morgan-healthcare-conference-in-focus?cid=CS-ZC-FT-346497 Jan 09, 2019 - It was a busy week for the biotech sector with most companies gaining on M&A activity. The annual J.P. Morgan Healthcare conference were also a key area of focus.
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer Presents at 37th Annual J.P. Morgan Healthcare Conference (Transcript) https://seekingalpha.com/article/4232079-regeneron-pharmaceuticals-inc-regn-ceo-leonard-schleifer-presents-37th-annual-j-p-morgan?source=feed_sector_transcripts Jan 08, 2019 - Regeneron Pharmaceuticals Inc (NASDAQ:REGN) 37th Annual J.P. Morgan Healthcare Conference January 7, 2019 1:30 PM ET Company Participants Leonard Schleifer - Founder, President and Chief Executive Off
4 Biotechs That Are Potential Buyouts Post Celgene Deal http://www.zacks.com/stock/news/346180/4-biotechs-that-are-potential-buyouts-post-celgene-deal?cid=CS-ZC-FT-346180 Jan 08, 2019 - We discuss a few attractive biotech companies that flaunt solid product portfolios, deep pipelines and lucrative valuations to emerge as likely acquisition targets in 2019.
Regeneron, Sanofi Restructure Immuno-Oncology Collaboration http://www.zacks.com/stock/news/346110/regeneron-sanofi-restructure-immuno-oncology-collaboration?cid=CS-ZC-FT-346110 Jan 07, 2019 - Regeneron (REGN) amends its existing agreement with Sanofi and selects two clinical-stage bispecific antibodies for the ongoing collaboration.
Stocks making the biggest moves premarket: LUV, TSLA, NFLX, INTC & more https://www.cnbc.com/2019/01/04/stocks-making-the-biggest-moves-premarket-luv-tsla-nflx-intc--more.html Jan 04, 2019 - Names on the move ahead of the open.
Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund https://seekingalpha.com/article/4230208-share-healthcare-biotech-gains-12-percent-yield-tekla-fund?source=feed_sector_healthcare Dec 27, 2018 - The biotech sector not only has helped to discover cures to difficult medical problems but also has outperformed the broader market. Tekla Healthcare Investors (HQH) is a CEF which provides investors
Long-Term Outlook For Regeneron Pharmaceuticals https://seekingalpha.com/article/4228998-long-term-outlook-regeneron-pharmaceuticals?source=feed_sector_healthcare Dec 18, 2018 - REGN is retracing its levels from January 2018 after hitting lows in May and highs in September.Revenue continues to grow and REGN has a strong history of growth.Still, there are concerns and sell-off
5 Excellent GARP Picks With Cheap PEG Ratio http://www.zacks.com/stock/news/343207/5-excellent-garp-picks-with-cheap-peg-ratio?cid=CS-ZC-FT-343207 Dec 17, 2018 - Although PEG ratio is categorized under value investing, this strategy follows the principles of both growth and value investing.

Pages: 123456...83

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ZTS Zoetis Inc. NYSE $88.3 $42.55B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $175.8 $44.93B
SHPG Shire plc NASDAQ $176.25 $46.08B
ALXN Alexion Pharmaceuticals, Inc. NASDAQ $117.77 $26.25B
TEVA Teva Pharmaceutical Industries Limited NYSE $23.43 $23.86B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Regeneron Pharmaceuticals
REGN - Google Finance https://www.google.com/finance?q=REGN Industry related info and international coverage Summary News
REGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=REGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options